At the BIO Investor Forum Oct 29-31 San Francisco, California
is Podcasting from the BIO Investor ForumEpilepsy Facts From the BIO Investor Forum
Get the facts now! Read the blog postLive From the BIO Investor Forum: Capital Access 201
Panelists at the opening plenary painted a startlingly realistic picture of the industry, but emphasized that this is the time for companies to be more aggressive and strategic in how they target and approach potential investors and partners. Read the blog postAlnylam Pharmaceuticals
Tracy Krughoff of BIO talks to Barry Greene, president and COO of Alnylam Pharmaceuticals Read the blog post
Valuation, Due Diligence, Negotiation, and Contracts
To compete in today's challenging environment you have to be at your very best. BIO's Advanced Business Development course can help you hone your skills in valuation, due diligence, negotiation and contracts to take your company (and your career) to the next level.
Sign up for the course
Regulatory Affairs Webinar
Building a strong working relationship with the FDA is critical to successful biopharmaceutical development. And, successful biopharmaceutical development is critical for a young company's bottom line. If you are an emerging biotech company executive, regulatory or clinical staff – Participate in this first webinar, Understanding Expectations and Regulatory Speak in Pre-IND to Phase II Stages of FDA Approval Process.
Sign up for the Webinar
Policy Updates
Small Business Innovation Research Grants (SBIR)
Not sure what the SBIR issue is? Check out our Hopes and Cures Blog, and find out why stamping out SBIR will also stamp out hope for cures.
